Skip to Main Content

Paper Details

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
Oncotarget
35
2017
ALDH1A3, CDK4, CDK4/6, CDK6, Cancer, E2F, E2F1, E2F1-regulated miR-1792 cluster, GBM, GSC lines, Glioblastoma, N,N-diethylaminobenzaldehyde, PN GSCs, Palbociclib, Rb1, brain tumor, glioblastoma, mice, microRNA, palbociclib, proneural, proneural GBM, proneural GSC, proneural GSC line, proneural GSCs, proneural subtype
Author NameAffiliation
Jeongwu LeeLerner Research Institute, Cleveland Clinic
Agnieszka BroniszBrigham and Women's Hospital
Krishna P BhatMD Anderson Cancer Center
Erik P SulmanMD Anderson Cancer Center
Erik P SulmanMD Anderson Cancer Center
  • 1 - 5

Datasets

Release 1.2